VisionBlue staining solution receives FDA approval

March 15, 2005

Kingston, NH—The FDA has approved D.O.R.C. International/Dutch Ophthalmic USA's New Drug Application for its patented VisionBlue staining solution for use in cataract surgery.

Kingston, NH-The FDA has approved D.O.R.C. International/Dutch Ophthalmic USA's New Drug Application for its patented VisionBlue staining solution for use in cataract surgery.

VisionBlue allows excellent visualization of the capsulorhexis in eyes with mature cataract or narrow pupils and provides a clear outline of the capsulorhexis rim during surgery.

The solution is sold in ready-to-use syringes and no mixing is required. It is available in sterile packs of 10 syringes of 0.5 ml per box. It has been available in Europe, Latin America, Asia, and Australia since 1999.